Respirology March 2023 PMID 36172951

Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study.

Timothy J W Dawes, Colm McCabe, Konstantinos Dimopoulos, Iain Stewart, Simon Bax, Carl Harries, Chinthaka B Samaranayake, Aleksander Kempny, Philip L Molyneaux, Samuel Seitler, Thomas Semple, Wei Li, Peter M George, Vasileios Kouranos, Felix Chua

Download social card

Mentions

Peak: 21 in Oct 2022

across 2 sources since Sep 2022

Extended reach

63,434

potential audience

Total likes

Video views

183

Mentions per month

Sep 2022 – Mar 2024

Where it's discussed

X / Twitter31 posts
YouTube3 videos

AI synopsis

What people are saying

The digital discussions emphasize the significance of PDE5 inhibitors in treating pulmonary hypertension associated with interstitial lung disease, with phrases like 'highlighting the limited treatment available' and 'apparent efficacy' reflecting cautious optimism. The tone varies from professional interest to cautious enthusiasm, and the repeated mention of survival and safety suggests a focus on potential clinical impact. The choice of words such as 'limited treatment' and 'safety and efficacy' indicate both acknowledgment of current challenges and hope for improved therapies based on this research.

AgreementModerate agreement

Most discussions acknowledge the potential benefits and positive implications of the study, reflecting a tentative agreement with the findings.

InterestHigh interest

The posts demonstrate high curiosity, especially with references to the key treatment and survival outcomes, indicating a strong relevance to the field.

EngagementModerate engagement

Several comments mention specific methodologies and implications, but overall, responses are more informational than deeply analytical.

ImpactModerate impact

While the discussion recognizes the importance of the research, the perceived impact appears moderate, with some users highlighting its preliminary nature or limitations.

All mentions

PDE5 Inhibitors and Survival in Interstitial Lung Disease with Pulmonary Hypertension

This study investigates whether phosphodiesterase 5 inhibitors improve survival in patients with lung scarring and pulmonary hypertension, following 128 patients to assess treatment impact on disease progression and…

Respirology Video · Oct 3, 2022 149 views

PDE5 Inhibitors and Survival in Lung Disease Pulmonary Hypertension

This video discusses the impact of phosphodiesterase 5 inhibitor treatment on survival rates in patients with interstitial lung disease-related pulmonary hypertension, based on a Bayesian retrospective cohort study.

Respirology Video · Dec 20, 2022 21 views

Phosphodiesterase 5 Inhibitors and Survival in Lung Disease-Linked Hypertension

This issue features recent research, including a study on how phosphodiesterase 5 inhibitors impact survival in interstitial lung disease-associated pulmonary hypertension.

Respirology Video · Oct 18, 2022 14 views

Faby G.

@Fabiolaghh · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Mar 15, 2024 · 10 shares · 410 followers View post →

Respirology

@RespirologyAPSR · X

RT @LavercombeMark: @RespirologyAPSR @APSRapsr The final article by Dawes et al highlights the limited treatment available for pulmonary hy…

Mar 8, 2023 · 1 share · 7,999 followers View post →

Mark Lavercombe

@LavercombeMark · X

@RespirologyAPSR @APSRapsr The final article by Dawes et al highlights the limited treatment available for pulmonary hypertension associated with ILD. They report on the safety and apparent efficacy of PDE5 inhibitors in ILD patients with PH, from their cohort at the Brompton. https://t.co/W3h0Ki0x5a

Mar 7, 2023 · 1 like · 1 share · 567 followers View post →

Unidad de Neumología HR

@NeumologiaHR · X

https://t.co/ltChGb7N4d

Feb 20, 2023 · 1 like · 1,269 followers View post →

Caesar De Melniboné

@CesarDMelnibone · X

RT @tipssovetorax: Inhibidores de fosfodiesterasa 5 y supervivencia en hipertesnion pulmonar asociada a enfermedad pulmonar intersticial: c…

Feb 20, 2023 · 4 shares · 125 followers View post →

Edgar Valoa

@Valoaborges · X

RT @tipssovetorax: Inhibidores de fosfodiesterasa 5 y supervivencia en hipertesnion pulmonar asociada a enfermedad pulmonar intersticial: c…

Feb 19, 2023 · 4 shares · 199 followers View post →

Angel E Vega-Sanchez

@AngelEVegaSanc1 · X

RT @tipssovetorax: Inhibidores de fosfodiesterasa 5 y supervivencia en hipertesnion pulmonar asociada a enfermedad pulmonar intersticial: c…

Feb 19, 2023 · 4 shares · 131 followers View post →

Sovetorax Tips

@tipssovetorax · X

Inhibidores de fosfodiesterasa 5 y supervivencia en hipertesnion pulmonar asociada a enfermedad pulmonar intersticial: cohorte observacional retrospectiva 1 https://t.co/yRnVhiWHWs

Feb 19, 2023 · 10 likes · 4 shares · 3,242 followers View post →

ASEMEVE

@asemeve · X

RT @RespirologyAPSR:

Nov 3, 2022 · 2 shares · 476 followers View post →

Respirology

@RespirologyAPSR · X

Nov 3, 2022 · 5 likes · 2 shares · 7,999 followers View post →

Respirology

@RespirologyAPSR · X

New research study in #Respirology: #Phosphodiesterase5inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A #Bayesian retrospective observational cohort study https://t.co/3U587D5wkd @timdawes2 @ImperialNHLI https://t.co/Iw0gDLxTyF

Oct 10, 2022 · 1 like · 7,993 followers View post →

georgepapadapol

@georgepapadapol · X

Tratamiento con inhibidores de Fosfodiesterasa-5 y supervivencia en sujetos con EPI e hipertensión pulmonar: #ILD

Oct 8, 2022 · 1,253 followers View post →

Alberto

@DrArzola · X

RT @NeumologiaPeru: Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension:

Oct 3, 2022 · 4 shares · 1,932 followers View post →

Carlos Andrés Celis-Preciado

@pulmonology101 · X

RT @NeumologiaPeru: Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension:

Oct 3, 2022 · 4 shares · 4,349 followers View post →

@NeumologoCervera

@wagner19921 · X

RT @NeumologiaPeru: Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension:

Oct 3, 2022 · 4 shares · 25 followers View post →

Juan Sebastián Sierra Duarte

@juanse10neumo · X

RT @NeumologiaPeru: Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension:

Oct 3, 2022 · 4 shares · 240 followers View post →

Alfredo Pachas

@AlfredoPachasMD · X

Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension:

Oct 3, 2022 · 7 likes · 4 shares · 1,763 followers View post →

noorulafidza

@afidzanoorul · X

RT @RespirologyAPSR: New research study in #Respirology: #Phosphodiesterase5inhibitor treatment and survival in interstitial lung disease p…

Oct 3, 2022 · 4 shares · 75 followers View post →

Pilar Rivera-Ortega

@PilarRiveraOrt1 · X

RT @RespirologyAPSR: New research study in #Respirology: #Phosphodiesterase5inhibitor treatment and survival in interstitial lung disease p…

Oct 3, 2022 · 4 shares · 3,516 followers View post →

Dr. Sergio Monraz Pérez. NeumologíaCdMX.

@SergioMonraz · X

RT @RespirologyAPSR: New research study in #Respirology: #Phosphodiesterase5inhibitor treatment and survival in interstitial lung disease p…

Oct 3, 2022 · 4 shares · 1,038 followers View post →

Respirology

@RespirologyAPSR · X

Oct 3, 2022 · 13 likes · 4 shares · 7,999 followers View post →

Alberto

@DrArzola · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 2, 2022 · 10 shares · 1,932 followers View post →

Dr. Sergio Monraz Pérez. NeumologíaCdMX.

@SergioMonraz · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 2, 2022 · 10 shares · 1,038 followers View post →

Dr. Eduardo Hevia

@heviaq · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 1, 2022 · 10 shares · 534 followers View post →

Marco Pérez

@mperezv12 · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 1, 2022 · 10 shares · 158 followers View post →

Alfredo Pachas

@AlfredoPachasMD · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 1, 2022 · 10 shares · 1,763 followers View post →

Angel E Vega-Sanchez

@AngelEVegaSanc1 · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 1, 2022 · 10 shares · 131 followers View post →

Sputnik my love ...

@SputnikMyLove_ · X

RT @KessnerJp: Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 1, 2022 · 10 shares · 343 followers View post →

jpedrokessner

@KessnerJp · X

Interstitial Lung Disease + Pulmonary Hypertension: treatment with PD5-inhib. and survival. https://t.co/LrffTFFHIq

Oct 1, 2022 · 31 likes · 10 shares · 1,600 followers View post →

Ricardo Bedón

@ricardo_bedon · X

RT @PH_Papers: Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrosp…

Sep 29, 2022 · 1 share · 1,498 followers View post →

PHpapers

@PH_Papers · X

Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study https://t.co/ivIDnhrxGg

Sep 29, 2022 · 3 likes · 1 share · 1,355 followers View post →

Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study.

Mentions per month

Where it's discussed

What people are saying

Top posts

All mentions

PDE5 Inhibitors and Survival in Interstitial Lung Disease with Pulmonary Hypertension

PDE5 Inhibitors and Survival in Lung Disease Pulmonary Hypertension

Phosphodiesterase 5 Inhibitors and Survival in Lung Disease-Linked Hypertension